Lenalidomide Adherence in Older Adults

Washington University School of Medicine17 enrolled

Overview

To describe patterns of adherence and pilot baseline measures to investigate factors associated with lower adherence to lenalidomide in older adults with myeloma.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Multiple Myeloma

Interventions

Medication Event Monitoring SystemOTHER

-Microchipped bottle cap

Eligibility

Sex: ALLMin age: 65 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Age ≥65 * Receiving lenalidomide for treatment of multiple myeloma. * Anticipated to receive ongoing care at Siteman Cancer Center and its satellite sites * Able to read and understand English. * Able to understand and willing to sign an IRB-approved written informed consent document. Exclusion Criteria: * Estimated life expectancy \<6 months. * Anticipated duration of lenalidomide therapy \<3 months. * Residing in a nursing facility where their medications are administered to them OR patient reports they do not self-administer their own medications.

Locations (1)

Washington University School of Medicine

St Louis, Missouri, United States

Outcomes

Primary Outcomes

Adherence rate as measured by the number of days in which the lenalidomide pill bottle was open

-Participants will be given a pill diary in which they will record if they opened the pill bottle without taking a medication (e.g. to ascertain remaining supply) to adjust the adherence rate accordingly

Time frame: Through completion of study (estimated to be 3 months)

Secondary Outcomes

Adherence rate as measured by a modified Brief Adherence Rating Scale

* Participants will fill out a brief survey about taking lenalidomide and an estimate of their adherence using a visual analog scale * Scored 0-100%, 0% = lenalidomide not taken on any days and 100% = lenalidomide taken every day

Time frame: Through completion of study (estimated to be 3 months)

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.